Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check21 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed. This reflects an update to the version history rather than changes to study data or descriptions.SummaryDifference0.0%

- Check77 days agoChange DetectedThe history page now shows Revision: v3.6.6 instead of v3.6.5, representing a small site update and not a change to the study record content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.